1 active not recruiting, 1 completed, 1 terminated. 3 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
Follow Ice: new trials by email Literature Review of Ice trials Research Report on Ice
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma Mosunetuzumab, DHAX, ICE - Large B-cell Lymphoma, High-grade B-cell Lymphoma | Phase 1 | Active not recruiting | Washington University School of Medicine | 24 | 2023-01-03 | 2026-01-08 |
| A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma ICE [ifosfamide+carboplatin+etoposide], GEMOX [gemcitabine+oxaliplatin], Tislelizumab - Peripheral T-cell Lymphoma, NK/T-cell Lymphoma | Phase 1 / Phase 2 | Terminated | Antengene Corporation | 56 | 2020-08-18 | 2026-01-05 |
| Intra-Cardiac Echocardiography Guided Cardioversion(ICE-CHIP) Study Intra-Cardiac Echocardiography guided Cardioversion, Intracardiac Echo, ICE - Atrial Fibrillation | Phase 1 / Phase 2 | Completed | EP MedSystems | 95 | 2005-03-01 | 2011-05-11 |
Atrial Fibrillation (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, T-Cell, Peripheral (1)
Antengene Corporation (1) · EP MedSystems (1) · Washington University School of Medicine (1)
United States (2) · China (1) · Netherlands (1)
David Russler-Germain, M.D., Ph.D. (1) · Sanjeev Saksena, MD, FACC (1) · Yang Yu, MD (1)